Biocon’s subsidiary Biocon Pharma has received the Food and Drug Administration’s permission for norepinephrine bitartrate injection (4 mg/4 ml, 1 mg/ml) in a single-dose vial, the company said in a ...

Intensive-care-experts-review-new-research-on-cardiac-outcomes-patient-distress-and-norepinephrine-dosing-standards ...

First and only manufacturer-prepared premix formulation of norepinephrine available Offers variety of storage options under refrigeration and at room temperature, allowing drug to be placed closer to ...

Rare Drug Side Effect Highlights Unique MS Feature PharMEDium Services, LLC announced a voluntary recall of 29 lots of 4mg Norepinephrine Bitartrate (16mcg/mL) added to 0.9% Sodium Chloride in 250mL ...

Baxter International announced the US Food and Drug Administration (FDA) approval and commercial launch of premix Norepinephrine Bitartrate in 5% dextrose injection (norepinephrine). Norepinephrine is ...

Norepinephrine is a catecholamine indicated for restoration of blood pressure in adult patients with acute hypotensive states. Baxter International has announced the commercial launch of premix ...

Baxter International Inc. BAX recently announced the receipt of the FDA’s approval and commercial launch of premix (ready-to-use) Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrine).

Long Grove Pharmaceuticals announced the strategic in-licensing of norepinephrine in 0.9% sodium chloride premix formulation from Nevakar Injectables. This manufactured, ready-to-use formulation is ...

PharMEDium Services has issued a voluntary recall of a total of 32 lots of norepinephrine bitartrate used to help treat blood pressure following complaints of discoloration in the admixture. The ...

(RTTNews) - Sterile medication producer Baxter International Inc. (BAX) announced Thursday that the U.S. Food and Drug Administration (FDA) approval and commercial launch of premix Norepinephrine ...